It is derived from the older mGluR group II agonist eglumegad, and led on to the development of the more potent compound LY-404,039, but is still widely used in research itself.
On je izveden iz starijeg agonista mGluR groupe II eglumegada, i doveo je do razvoja potentnijeg jedinjenja LY-404,039, ali se još uvek koristi u istraživanjima.